These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38600789)

  • 21. Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms.
    Treitler PC; Bowden CF; Lloyd J; Enich M; Nyaku AN; Crystal S
    J Subst Abuse Treat; 2022 Jan; 132():108514. PubMed ID: 34098210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.
    Hailu R; Mehrotra A; Huskamp HA; Busch AB; Barnett ML
    JAMA Netw Open; 2023 Jan; 6(1):e2252381. PubMed ID: 36692880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review.
    Guillen AG; Reddy M; Saadat S; Chakravarthy B
    Telemed J E Health; 2022 Jun; 28(6):761-767. PubMed ID: 34714172
    [No Abstract]   [Full Text] [Related]  

  • 25. Telehealth sustains patient engagement in OUD treatment during COVID-19.
    Langabeer JR; Yatsco A; Champagne-Langabeer T
    J Subst Abuse Treat; 2021 Mar; 122():108215. PubMed ID: 33248863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative study to determine perspectives of clinicians providing telehealth opioid use disorder treatment.
    Burke B; Miller E; Clear B; Weiner SG
    Drug Alcohol Depend; 2024 Mar; 256():111118. PubMed ID: 38367534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study.
    Wyte-Lake T; Cohen DJ; Williams S; Casey D; Chan M; Frank B; Levander XA; Stein D; White KK; Bailey SR
    J Gen Intern Med; 2024 Sep; 39(12):2179-2186. PubMed ID: 38228990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telehealth Utilization Is Associated with Lower Risk of Discontinuation of Buprenorphine: a Retrospective Cohort Study of US Veterans.
    Vakkalanka JP; Lund BC; Ward MM; Arndt S; Field RW; Charlton M; Carnahan RM
    J Gen Intern Med; 2022 May; 37(7):1610-1618. PubMed ID: 34159547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.
    Lin LA; Fortney JC; Bohnert ASB; Coughlin LN; Zhang L; Piette JD
    J Subst Abuse Treat; 2022 Feb; 133():108492. PubMed ID: 34175175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky.
    Lei F; Lofwall MR; Freeman PR; Slade E; Vickers-Smith R; Slavova S
    J Rural Health; 2023 Jan; 39(1):186-196. PubMed ID: 35610181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.
    Krawczyk N; Bunting AM; Frank D; Arshonsky J; Gu Y; Friedman SR; Bragg MA
    Int J Drug Policy; 2021 Jun; 92():103140. PubMed ID: 33558165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters.
    Uscher-Pines L; Raja P; Mehrotra A; Huskamp HA
    J Subst Abuse Treat; 2020 Aug; 115():108037. PubMed ID: 32600625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telehealth Utilization for Opioid Use Disorder: A Nationwide Analysis Before and After the COVID-19 Public Health Emergency Declaration.
    Lewis KN; Zhang D; Corrales G; Eswaran H; Hayes CJ; Gressler LE
    Telemed J E Health; 2024 Jun; 30(7):e1980-e1989. PubMed ID: 38621153
    [No Abstract]   [Full Text] [Related]  

  • 35. Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C.
    Yeo EJ; Kralles H; Sternberg D; McCullough D; Nadanasabesan A; Mayo R; Akselrod H; Catalanotti J
    Harm Reduct J; 2021 Dec; 18(1):127. PubMed ID: 34886850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broadband access and telemedicine adoption for opioid use disorder treatment in the United States.
    Ali MM; Ghertner R
    J Rural Health; 2023 Jan; 39(1):233-239. PubMed ID: 35838414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
    Weintraub E; Seneviratne C; Anane J; Coble K; Magidson J; Kattakuzhy S; Greenblatt A; Welsh C; Pappas A; Ross TL; Belcher AM
    JAMA Netw Open; 2021 Aug; 4(8):e2118487. PubMed ID: 34448869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
    Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
    Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leveraging Policy Changes Made in Response to COVID-19 to Advance Telehealth and Novel Treatment Approaches for People Who Use Opioids: Qualitative Perspectives From Two Rural North Carolina Counties.
    Chen H; Knettel BA; Macon Harrison L; Des Marais A; Nelli A; Campbell HA; Muhirwa A; McKellar MS; Gulur P; Guthrie S
    N C Med J; 2023 Jul; 84(5):335-341. PubMed ID: 39312782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient experiences with telehealth treatment for opioid use disorder in Alabama.
    Weiner SG; Burgess A; Singh H; Miller EN; Murphy C; Chehregosha E; Clear B
    J Subst Use Addict Treat; 2024 Oct; 165():209451. PubMed ID: 38960146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.